Search hospitals > Hawaii > Honolulu

Queen's Medical Center

Claim this profile
Honolulu, Hawaii 96813
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for HIV Infection
433 reported clinical trials
26 medical researchers
Photo of Queen's Medical Center in HonoluluPhoto of Queen's Medical Center in Honolulu

Summary

Queen's Medical Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, HIV Infection and other specialties. Queen's Medical Center is involved with conducting 433 clinical trials across 584 conditions. There are 26 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.

Area of expertise

1Breast Cancer
Global Leader
Queen's Medical Center has run 71 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
ER positive
2Lung Cancer
Global Leader
Queen's Medical Center has run 61 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Queen's Medical Center

Lung Cancer
Breast Cancer
Breast cancer
Cancer
Ovarian Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Esophageal cancer
Oropharyngeal Carcinoma
Throat Cancer
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Queen's Medical Center?
Where is Queen's Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Queen's Medical Center accept?
What awards or recognition has Queen's Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security